FDA upgrades children's ibuprofen nationwide Class II recall
Nearly 80,563 bottles of Childrens Ibupr Oral Suspension have been recalled after reports from consumers and healthcare providers indicated the presence of a gel-like substance or foreign material. The FDA has upgraded this voluntary Class II recall to address potential safety risks associated with possible contamination in products manufactured by Strides Pharma Inc., which were sold nationwide since March 2019, though no injuries linked directly to these bottles have been reported yet as per federal regulators' latest assessment on the matter today (Mar.
Key Points
-
1The U.S. FDA has initiated a nationwide Class II recall of nearly 90,000 bottles of Children's Ibuprofen Oral Suspension.
-
2Pharmaceutical manufacturer Strides Pharma voluntarily recalled the product due to reports containing foreign material described as 'gel-like mass'.
-
3Health officials have received no specific injuries or illnesses linked directly to this particular batch despite potential contamination concerns.
Developments
Perspectives
The FDA has not received any reports of injuries or illnesses in connection with this recalled product.
— (Mar 19, 20:57) Children's ibuprofen under recall for 'foreign substance' (The Independent)"Nearly 90K bottles" have been "recalled nationwide after complaints of gel-like mass."
— [Nypost]Pharmaceutical company Strides Pharma Inc issued the voluntary recall March because they believed it could contain a foreign substance.
— (Mar 19, 20:57) Children's ibuprofen under recall for 'foreign substance' (The Independent)"Quase" "mil frascos de ibuprofeno infantil recolhidos ap͍ s queixas de contaminac\u00e1o."
— (Mar 19, 20:57) Children's liquid oral suspension recalled nationwide after reports of possible contamination (Sapo.pt)"Nearly" "bottles ... have been recall[ed]... with health officials saying the medicine could contain a foreign substance."
— (Mar 19, 20:57) Children's ibuprofen under recall for 'foreign substance' (The Independent), NBC ChicagoThe FDA has upgraded a nationwide recall to Class II after Strides Pharma reported that nearly 90,000 bottles of children's ibuprofen contained foreign substances like gel-like masses. Although no injuries or illnesses have been linked to the contaminated medication with lot numbers ending in A and an expiration date before January 31, 2027, consumers are advised to stop using affected products immediately due to potential temporary health risks.
The FDA has issued a Class II recall of nearly 90,000 bottles of Children's Ibubrophen Oral Suspension after consumers reported finding gel-like masses inside the medication manufactured by Strides Pharma Inc., which was distributed for Taro Pharmaceuticals USA. The voluntary action affects specific lots expiring on January 31, 2027; while no injuries have been confirmed in reports yet and complaint numbers remain undisclosed to date.
The U.S. Food and Drug Administration has initiated a nationwide Class II recall for nearly 90,000 bottles of Children's Ibuprofen Oral Suspension manufactured by Taro Pharmaceuticals due to reports of gel-like masses and black particles inside the product. Consumers are advised not to use or consume any affected lots (7261973A/4B) with an expiration date before January 31, 2025